Fexofenadine Hydrochloride
Fexahist Allergy Contains Fexofenadine Hydrochloride, Which is an Antihistamine.
Fexahist Allergy 120 mg is Used in Adults and Adolescents 12 Years of Age and Older to Relieve the Symptoms of Allergic Rhinitis (e.g., Hay Fever), Such as Sneezing, Nasal Itching, Runny or Stuffy Nose, and Itchy, Red, or Teary Eyes.
If There is no Improvement or You Feel Worse After 7 Days, Consult a Doctor.
Before Taking Fexahist Allergy, Discuss with Your Doctor or Pharmacist if You Have:
If any of these Conditions Apply to You or if You are in Doubt, Inform Your Doctor Before Taking Fexahist Allergy.
Fexahist Allergy is not Recommended for Children Under 12 Years of Age.
For Children Aged 6 to 11 Years: Fexofenadine Hydrochloride 30 mg Tablets are the Appropriate Form for this Age Group.
Tell Your Doctor or Pharmacist About all Medications You are Currently Taking or Have Recently Taken, as well as any Medications You Plan to Take.
If You are Taking Apalutamide (a Medication Used to Treat Prostate Cancer), the Effect of Fexofenadine may be Reduced.
It is Especially Important to Consult Your Doctor Before Taking Fexofenadine if You are Also Taking any of the Following Medications:
These Medications Increase the Amount of Fexofenadine Absorbed.
Antacids Containing Aluminum and Magnesium may Affect the Action of Fexahist Allergy, Reducing the Amount of Medication Absorbed.
A 2-Hour Interval is Recommended Between Taking Fexahist Allergy and an Antacid.
If You are Pregnant or Breastfeeding, Think You may be Pregnant or are Planning to Have a Baby, Consult Your Doctor or Pharmacist Before Taking this Medication.
Do not Take Fexahist Allergy if You are Pregnant, Unless Your Doctor Recommends it.
Fexahist Allergy is not Recommended During Breastfeeding.
It is Unlikely that Fexahist Allergy will Affect Your Ability to Drive or Use Machines. However, Before Driving or Using Machines, Make Sure that this Medication does not Cause Drowsiness or Dizziness.
If You have been Diagnosed with an Intolerance to Some Sugars, Consult Your Doctor Before Taking this Medication.
This Medication Contains Less than 1 mmol (23 mg) of Sodium per Tablet, Which Means it is Essentially Sodium-Free.
Always Take this Medication Exactly as Described in this Package Leaflet for the Patient or as Advised by a Doctor or Pharmacist. If in Doubt, Consult a Doctor or Pharmacist.
The Recommended Dose is 1 Tablet (120 mg) per Day.
Take the Tablet Before a Meal, with a Glass of Water.
This Medication Starts to Relieve Symptoms Within 1 Hour and its Effect Lasts for 24 Hours.
If You Have Taken Too Many Tablets, Contact a Doctor or Pharmacist or the Nearest Hospital Emergency Department Immediately. Symptoms of Overdose in Adults Include: Dizziness, Drowsiness, Fatigue, and Dry Mouth.
Do not Take a Double Dose to Make Up for a Missed Dose.
Take the Next Dose at the Usual Time, as Advised.
If You Stop Taking Fexahist Allergy, Symptoms may Return.
If You Have any Further Questions on the Use of this Medication, Consult a Doctor or Pharmacist.
Like all Medications, Fexahist Allergy can Cause Side Effects, Although not Everybody Gets them.
In Clinical Trials, the Following Side Effects were Reported, with a Frequency Similar to that Observed in Patients who did not Receive the Medication (Placebo).
Common Side Effects(may Affect up to 1 in 10 People):
Uncommon Side Effects(may Affect up to 1 in 100 People):
Other Side Effects(Frequency not Known: Cannot be Estimated from the Available Data), Which may Include:
If You Experience any Side Effects, Including those not Listed in this Package Leaflet, Tell Your Doctor or Pharmacist. Side Effects can be Reported Directly to the Department for the Monitoring of Adverse Reactions to Medicinal Products, Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych, Al. Jerozolimskie 181C, 02-222 Warszawa, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl
Side Effects can also be Reported to the Marketing Authorization Holder.
By Reporting Side Effects, You can Help Provide More Information on the Safety of this Medication.
Keep this Medication out of the Sight and Reach of Children.
Do not Use this Medication After the Expiry Date Stated on the Carton and Blister After: EXP.
The Expiry Date Refers to the Last Day of the Month Stated.
No Special Precautions for Storage are Required.
Medications should not be Disposed of via Wastewater or Household Waste. Ask Your Pharmacist How to Dispose of Medications no Longer Required. This will Help Protect the Environment.
The Active Substance is Fexofenadine Hydrochloride.
Each Film-Coated Tablet Contains 120 mg of Fexofenadine Hydrochloride, Which Corresponds to 112 mg of Fexofenadine.
The Other Ingredients are:
Tablet Core: Sodium Carboxymethylcellulose, Lactose, Lactose Monohydrate, Corn Starch, Silicon Dioxide, Povidone, Stearic Acid.
Tablet Coating: Red Iron Oxide (E 172), Yellow Iron Oxide (E 172), Hypromellose Type 2910 6 mPas (E 464), Macrogol 400 (E 1521), Titanium Dioxide (E 171).
Film-Coated Tablet
Peach-Colored, Capsule-Shaped, with a Score Line, Biconvex, with the Engraving "FE" on one Side and "120" on the Other Side.
Fexahist Allergy, 120 mg, Film-Coated Tablets are Available in Blisters of 7, 10, 15, and 20 Film-Coated Tablets, in a Cardboard Box.
Not all Pack Sizes may be Marketed.
Aurovitas Pharma Polska Sp. z o.o.
ul. Sokratesa 13D lokal 27
01-909 Warszawa
e-mail: medicalinformation@aurovitas.pl
APL Swift Services (Malta) Ltd.
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
Generis Farmacêutica, S.A.
Rua João de Deus 19, Venda Nova
2700-487 Amadora
Portugal
Arrow Generiques
26 Avenue Tony Garnier
69007 Lyon
France
France:
Fexofenadine Arrow 120 mg Film-Coated Tablet
Germany:
Fexofenadine PUREN 120 mg Film-Coated Tablets
Netherlands:
Fexofenadine HCl Aurobindo 120 mg, Film-Coated Tablets
Poland:
Fexahist Allergy
Portugal:
Fexofenadina Generis
Spain:
Riniwel 120 mg Film-Coated Tablets EFG
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.